{"nct_id":"NCT06190951","title":"A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-09-18","start_date_type":"ACTUAL","primary_completion_date":"2027-03-11","primary_completion_date_type":"ESTIMATED","completion_date":"2031-04-23","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["REGN"]}